THIS SHOULD BE OF ENCOURAGEMENT TO US...  HERES THE

New Post Public Reply Private Reply Replies (1) Message Board
highflier
THIS SHOULD BE OF ENCOURAGEMENT TO US... 

HERES THE FACTS ON PRICE MOVEMENT TO VOLUME RATIO...

Looks like we have been warned over and over and over again that this stock will never go up because of all the diluted shares. Well according to the charts, if we compare price movement and volume the dilution is not hindering the stock price to run.
Lets go to bigcharts and see the facts for ourselves.


http://bigcharts.marketwatch.com/interchart/i...amp;freq=3

Once you open the link go to the left box click timeframe , then click chart range , then click 2 years .

Now lets look at volume and price movement. That is the telling story with the tradeable float. Slide your cursor on the bottom part of the chart and you will see for yourself the volume/date and price.
Date.............Price....Volume
Jan 27,2012 .0008 92,780,424
Feb 3, 2012 .001 138,243,856
Feb 10,2012 .003 148,966,600
Feb 17,212 .008 676,904,500
Total Volume 1,056,895,380 That is over 1 billion shares
traded in 3 weeks.
Float at this time was only 379,000,000


Date.............Price....Volume
March 9, 2012 .004 85,953,790
March 16,2012 .007 146,009,456
March 23,2012 .017 335,275,736
March 30,2012 .018 287,097,184
Total Volume 854,336,166 Over 3/4 million shares traded in
3 weeks and a 350% increase in price. Also remember we had big news that came out on March 23 that drove the price.
Float at this time was only 379,000,000 .


Date...........Price....Volume
Feb 1,2013 .004 42,879,750
Feb 8,2013 .004 119,606,072
Feb 15,2013.006 103,673,360
Feb 22,2013.008 92,857,000
Total Volume 359,016,182, thats 58% less volume then the run we had from March 9th thru March 30th. Price increase of 100%.
Float at this time was 640,000,000.
A 41% increase in shares from the March 2012 run and yet the price moved just as easily.


Even the run up the July 18 went from .002 to .0038 on only 105,000,000 shares that day. Up over 80% and with a float of over 850,000,000 shares !!

These are FACTS that can't be dispelled no matter what anyone says. Yes the FACTS are they increased the O/S by 261 million shares during that time. But the FACTS also tells us those shares are not in the open market ,(meaning when SNDY is selling these shares someone is buying them instead of them being just dumped into the open float of tradeable shares). If the float was that much bigger it would of taken at LEAST TWICE AS MUCH VOLUME TO MOVE THE STOCK PRICE UP ON THE RUN BACK IN FEBRUARY 2013.

I would agree with what many are saying about them diluting shares if they were being added to the tradeable float. The stock price would be very very hard to move up when you have a much larger float. But the FACTS shown in this chart with the price to volume ratio just do not support that the dilution will kill any run up in price. Sorry but it is simply the facts.

Yes SNDY has been selling shares but a lot of people on this board are buying. And this chart tells us that someone is buying them instad of them being dumped in the open market. Booper, Muff1, Blueski, Mgergo, Pennylanepam, Vert, Elcappy1, Frazier, Ichase01, Aqua and many others including myself have been buying millions of shares since February 2012. And the chart says exactly that.

I believe when we get volume of over 750,000,000 in a weeks time we will see this price run back up like it did last year. This time if it is good news driving the price you will have more people coming into buy then before. Last years move was on news of speculation. This time it will be because of what they have achieved in obtaining the CE mark and having a company, EG, that will open up major distribution channels and can help them in getting merger deals done. Also there are many eyes watching on the sidelines to buy this stock because they know just how fast it can run. Let them buyers come in and it can run right past the .024 that was made last year. For that to happen the major longs that do own millions of shares will have to be patience and let the price run. Also last time we had our run the company was selling shares. We know now it looks like they want be selling any share until Feb. 2014. So any price movement this time should not be met with any resistance of the company selling shares.

Now we have to do our part. If we all do own a major chunk of the shares, then we own a very large amount of the float. If we don't sell on the run up then the price will have to run higher because demand will be greater then the the supply of shares available. I believe once we break the .01 mark firmly then we will loose alot of the flippers and we will see the price move quickly from there. All it will take is major news. CE Mark will be starters, then big increase in revenue, along with a merger/buyout right after CE Mark or down the road after sales revenue increase. I still say this has merger/buyout written ALL OVER IT!

Take care my friends,
Mike 

CYduct Diagnostics Inc. (CYDX) Stock Research Links

CYDX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 127

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 163

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Senator Whitehouse Addresses Challenges in Climate Summit Attendance

Updated Category News Views 330

Senator Whitehouse's Message on Climate Action Sen. Sheldon Whitehouse emphasized a direct message at this year's U.N. climate summit. He assured global negotiators that the United States remains dedicated to climate action, despite the challenges faced during the Trump administration. Challenges at the U.N. Climate Summit Whitehouse specifically pointed out internal...

Continue Reading
The Surge of Spearmint Oil: Insights on Market Growth to 2033

Updated Category News Views 125

Growing Potential of the Spearmint Oil Market Allied Market Research has revealed exciting projections for the spearmint oil market, anticipating it will escalate from a valuation of $180.1 million in recent years to an impressive $377.5 million by 2033, all the while attaining a compound annual growth rate (CAGR) of 7.7% from 2024 to 2033. Factors Fueling Market...

Continue Reading
Exploring Adobe's Stock Growth Track Record Over Two Decades

Updated Category News Views 212

Adobe Stock: A 20-Year Investment Journey Adobe Inc (NASDAQ: ADBE) has demonstrated exceptional stock performance over the past twenty years, consistently outpacing market averages by 5.02% annually. This remarkable growth culminates in an average annual return of 13.66%, showcasing the strength of Adobe’s business model and innovative contributions to the tech...

Continue Reading
Virginia Housing Program Expands Access with New Limits

Updated Category News Views 187

Virginia Housing Introduces New Income and Sales Price Limits Recently, Virginia Housing announced significant updates regarding the maximum gross household income and sales price limits for homebuyers. This change is destined to benefit numerous first-time and repeat homebuyers across the state of Virginia. With these updates, a wider range of individuals and families...

Continue Reading
DraftKings Poised for Strong Growth in Revenue and Earnings

Updated Category News Views 219

Analysts Optimistic About DraftKings' Future Growth DraftKings Inc (NASDAQ: DKNG) is garnering attention as analysts assess the company's outlook for 2025 following its recent fourth-quarter results. Industry experts are weighing in on the potential for substantial growth in revenue and earnings, indicating a positive trajectory for the company. Strong Analyst Ratings...

Continue Reading